In a 24-year-old woman who received naproxen two hours ago, can ketorolac be administered intramuscularly?

No, Do Not Give Ketorolac IM After Recent Naproxen

You should not administer ketorolac intramuscularly to this patient who received naproxen just 2 hours ago. Combining two NSAIDs simultaneously provides no additional analgesic benefit and significantly increases the risk of serious gastrointestinal bleeding, renal toxicity, and cardiovascular complications.

Why This Combination Is Contraindicated

Both naproxen and ketorolac are NSAIDs that work through the same mechanism—inhibiting cyclooxygenase (COX) enzymes. When given together, they:

• Do not provide additive analgesia because they compete for the same receptor sites
• Dramatically increase GI bleeding risk through cumulative prostaglandin inhibition 1
• Compound renal toxicity, particularly concerning in any patient with volume depletion or pre-existing renal compromise 1
• Amplify antiplatelet effects, creating excessive bleeding risk 1, 2

The FDA labeling for ketorolac explicitly warns about serious GI adverse events including bleeding, ulceration, and perforation that "can occur at any time, with or without warning symptoms" 1. These risks are magnified when NSAIDs are combined.

Clinical Reasoning

Naproxen's pharmacokinetics make overlap particularly problematic:

• Naproxen has a half-life of 12-17 hours with dosing every 8-12 hours 3
• Peak plasma concentrations occur 2-4 hours after oral administration
• At 2 hours post-dose, the patient is at or near peak naproxen levels
• Adding ketorolac at this point creates maximum NSAID exposure

Ketorolac offers no therapeutic advantage here:

• If naproxen at 2 hours hasn't provided adequate relief, adding another NSAID won't solve the problem
• The issue is either inadequate initial dosing, wrong drug class selection, or pain severity requiring a different approach

What To Do Instead

If the patient needs additional analgesia:

1. Wait at minimum 6-8 hours from the naproxen dose before considering ketorolac, though ideally wait for the next scheduled naproxen dose interval to pass completely

2. Choose a different analgesic class immediately:

   • Acetaminophen 1000 mg (can be combined safely with NSAIDs) 4
   • Opioid analgesics if pain severity warrants (meperidine 50-150 mg IM, though avoid if possible due to toxicity concerns) 3
   • Consider adjunctive therapies like metoclopramide 10 mg IV if nausea is present 3

3. Reassess the pain management strategy:

   • Was the initial naproxen dose adequate? (therapeutic dose is 500-550 mg) 3
   • Is this pain severity appropriate for NSAID monotherapy?
   • Consider multimodal analgesia with different drug classes rather than NSAID stacking 4

Important Caveats

The bleeding risk is real and documented: A case report demonstrated that even a single 30 mg IM dose of ketorolac, when combined with other antiplatelet agents (fluoxetine, fish oil, vitamin E), contributed to a catastrophic spinal epidural hematoma causing tetraplegia 2. While this was in the context of a spinal procedure, it illustrates the serious hemorrhagic potential of ketorolac, especially with concurrent antiplatelet medications.

Special considerations for this 24-year-old woman:

• If she's taking oral contraceptives, SSRIs, or other medications, check for additional drug interactions
• Ensure she's not pregnant (ketorolac is contraindicated in pregnancy) 1
• Verify no history of GI ulcers, bleeding disorders, or aspirin-sensitive asthma 3, 1

If ketorolac is truly needed later:

• Maximum duration is 5 days total 1
• Dose for young adults <65 years: 30 mg IV over ≥15 seconds or 60 mg IM 1
• Monitor for GI symptoms, renal function changes, and bleeding 1

The evidence consistently shows that multimodal analgesia using different drug classes is superior to combining drugs from the same class 4. Choose acetaminophen or an opioid now, and reserve ketorolac for later if NSAIDs remain the appropriate choice after the naproxen has cleared.